Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

19.88
-0.6200-3.02%
Post-market: 19.890.0100+0.05%19:55 EDT
Volume:1.15M
Turnover:23.02M
Market Cap:3.87B
PE:-39.70
High:20.59
Open:20.42
Low:19.85
Close:20.50
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:0.86
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.14
PE(LYR):-12.27

Loading ...

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

Legend Biotech Corporation : TD Cowen Cuts Target Price to $24 from $29

THOMSON REUTERS
·
Aug 12

TD Cowen Sticks to Its Hold Rating for Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
Aug 12

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Legend Biotech Shares Rise After Swinging to 2Q Profit, Higher Revenue

Dow Jones
·
Aug 11

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Reuters
·
Aug 11

GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026

Reuters
·
Aug 11

Legend Biotech Rises After Second Quarter Results Beat Estimates

Reuters
·
Aug 11

Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year

Reuters
·
Aug 11

Legend Biotech Q2 Adj. EPS $0.16 Beats $0.07 Estimate, Sales $387.500M Beat $355.772M Estimate

Benzinga Earnings
·
Aug 11

Legend Biotech Corporation - Carvykti Net Trade Sales Increase 50% in Q2 2026 to $657 Mln

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 Adjusted EPS USD 0.16 VS. Ibes Estimate USD 0.07

THOMSON REUTERS
·
Aug 11

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

THOMSON REUTERS
·
Aug 11

After Multiple Bearish Catalysts, Legend Biotech's Stock Halved in Two Months: Value Trap or Bargain Opportunity?

Stock News
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Legend Biotech Corporation Expected to Post Earnings of 7 Cents a Share - Earnings Preview

Reuters
·
Aug 08